Skip to content
March 28, 2024

Equity.Guru

Investment information for the new generation

Search

3a Diagnostics

XPhyto Therapeutics (XPHY.C), with its partner and acquisition target, 3a-diagnostics GmbH announced today that it has successfully registered its first biosensor test in oral inflammation with the German authorities….